Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Espejo

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Clinical Immunology (Orlando, Fla.)|July 12, 2011
Dalfampridine in multiple sclerosis: from symptomatic treatment to immunomodulationCarmen Espejo, Xavier Montalban
Annals of the New York Academy of Sciences|August 30, 2005
The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosisCarmen Espejo, Eva M Martínez-Cáceres
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 6, 2015
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level-NOGeorgina Arrambide, Carmen Espejo, Mar Tintore
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2021
Correcting gut dysbiosis can ameliorate inflammation and promote remyelination in multiple sclerosis - YesLaura Calvo-Barreiro, Marinella Clerico, Carmen Espejo
Molecular Medicine (Cambridge, Mass.)|June 7, 2012
Heat shock protein 70: roles in multiple sclerosisMaría José Mansilla, Xavier Montalban, Carmen Espejo
Annals of Neurology|December 11, 2023
Reply to "Myelin Oligodendrocyte Glycoprotein Antibody-Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions"Javier Villacieros-Álvarez, Carmen Espejo, Álvaro Cobo-Calvo
Trends in Molecular Medicine|February 20, 2013
Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosisHerena Eixarch, Ana Gutiérrez-Franco, Xavier Montalban, et al.
Autoimmunity Reviews|December 2, 2017
Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosisLaura Calvo-Barreiro, Herena Eixarch, Xavier Montalban, et al.
Brain, Behavior, and Immunity|March 3, 2017
Bone morphogenetic proteins in multiple sclerosis: Role in neuroinflammationHerena Eixarch, Laura Calvo-Barreiro, Xavier Montalban, et al.
Clinical Immunology (Orlando, Fla.)|June 17, 2015
Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis inductionEster Cantó, Carmen Espejo, Carme Costa, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Clinical Immunology (Orlando, Fla.)|July 12, 2011
Dalfampridine in multiple sclerosis: from symptomatic treatment to immunomodulationCarmen Espejo, Xavier Montalban
Annals of the New York Academy of Sciences|August 30, 2005
The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosisCarmen Espejo, Eva M Martínez-Cáceres
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 6, 2015
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level-NOGeorgina Arrambide, Carmen Espejo, Mar Tintore
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2021
Correcting gut dysbiosis can ameliorate inflammation and promote remyelination in multiple sclerosis - YesLaura Calvo-Barreiro, Marinella Clerico, Carmen Espejo
Molecular Medicine (Cambridge, Mass.)|June 7, 2012
Heat shock protein 70: roles in multiple sclerosisMaría José Mansilla, Xavier Montalban, Carmen Espejo
Annals of Neurology|December 11, 2023
Reply to "Myelin Oligodendrocyte Glycoprotein Antibody-Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions"Javier Villacieros-Álvarez, Carmen Espejo, Álvaro Cobo-Calvo
Trends in Molecular Medicine|February 20, 2013
Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosisHerena Eixarch, Ana Gutiérrez-Franco, Xavier Montalban, et al.
Autoimmunity Reviews|December 2, 2017
Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosisLaura Calvo-Barreiro, Herena Eixarch, Xavier Montalban, et al.
Brain, Behavior, and Immunity|March 3, 2017
Bone morphogenetic proteins in multiple sclerosis: Role in neuroinflammationHerena Eixarch, Laura Calvo-Barreiro, Xavier Montalban, et al.
Clinical Immunology (Orlando, Fla.)|June 17, 2015
Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis inductionEster Cantó, Carmen Espejo, Carme Costa, et al.
Pageof 9